Real‐World Trends and Outcomes for Localized High‐Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia
Treatment patterns evolved over time, reflecting emerging evidence, but no significant RFS or OS differences were observed. Further research is needed, including exploring prognostic factors like elevated baseline FDG-PET SUVmax.
Authors
- David Gyorki (ORCID: https://orcid.org/0000-0002-3165-4694)
- Sarah O'Reilly‐Harbidge
- Anne Hamilton (ORCID: https://orcid.org/0000-0003-0368-9838)
- Hayden Snow (ORCID: https://orcid.org/0000-0002-0579-1193)
- Adel Shahnam (ORCID: https://orcid.org/0000-0002-0043-8374)
- Catherine Mitchell (ORCID: https://orcid.org/0000-0003-3069-6590)
- Jeremy Howard Lewin (ORCID: https://orcid.org/0000-0002-4305-117X)
- Suchen Fong
- Sarat Chander (ORCID: https://orcid.org/0000-0002-1803-049X)
- Julie Chu (ORCID: https://orcid.org/0000-0002-5043-8508)
- Lisa Orme (ORCID: https://orcid.org/0000-0002-9398-6977)
- Jayesh Desai (ORCID: https://orcid.org/0000-0003-4246-9344)
- Susie Bae (ORCID: https://orcid.org/0000-0002-4514-4142)
- Claudia Di Bella (ORCID: https://orcid.org/0000-0001-9980-8672)
- Grant Pang
- Stephen J. Luen
- John Slavin
Institutions
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- St Vincent's Hospital Melbourne (AU)
- St Vincent’s Private Hospital Sydney (AU)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1111/ajco.70043
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00